Luke, Jason J <br/><br/>
Similar efficacy for phase I trials in comparison with DTIC for advanced malignant melanoma: an analysis of melanoma outcomes in CTEP-sponsored phase I trials 1995-2011.  [electronic resource] 

 -  Melanoma research  Apr 2013 
 - 152-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1473-5636 
<br/><br/><label>Standard No.: </label>10.1097/CMR.0b013e32835f73b2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase III as Topic<br/>Dacarbazine--adverse effects<br/>Female<br/>Humans<br/>Immunotherapy<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Retrospective Studies<br/>Skin Neoplasms--drug therapy